CLINICAL PRESENTATION AND MANAGEMENT OF PERTUSSIS

More documents

Recommendations

Info

Control of Patient & Contacts• IsolationSuspected cases not received antibiotics-isolated for3 weeks esp from young child & un-immunizedinfant.Isolation of contact:- symptomatic-3 week- asymptomatic h/care worker notreceiving a/b- ? 5 day- 3 week• Quarantine- excluded from school/daycare/public gatherings for3 weeks
Treatment & Prophylaxis• Tx- recommended antimicrobial agents• The need for prophylaxis in the following high riskgroups is particularly important:i. infantsii.non-immunized childreniii.immunocompromised individualsiv.pregnant womenv.individuals with chronic respiratory illness,including asthmatics
Page 1 and 2: DR HASNI IBRAHIMFMSKK SELISING
Page 3 and 4: DTaP-IPV/Hib - KomposisiDifteriaHib
Page 5 and 6: PERTUSSIS• Respiratory infection
Page 7 and 8: CLINICAL PRESENTATION• Illness is
Page 9 and 10: • Paroxysmal• Coughing spells w
Page 11 and 12: Stages of pertussis inf and period
Page 13 and 14: Laboratory diagnosisDetection of B
Page 15 and 16: • PCR assay for B pertussisRecomm
Page 17 and 18: • Prophylaxis• Significant expo
Page 19 and 20: Disease SurveillanceCase Definition
Page 21 and 22: Case Classification; Pertussis• S
Page 23 and 24: Purpose of reporting & investigatio
Page 26 and 27: Outbreak investigationDefinition of
Page 30 and 31: Control in Healthcare settings• C
Page 32 and 33: Preventive Measures• Educate the

CLINICAL PRESENTATION AND MANAGEMENT OF PERTUSSIS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?